Orkla har på siste utøvelsesdag den 15. desember 2009 innløst, under sitt
opsjonsprogram for ledere, 477 500 opsjoner til snittkurs kroner 35,57 samt
100Â 000 kontantbonus til snittkurs kroner 21,13.
De primærinnsidere som har innløst opsjoner, har alle mottatt Orkla-aksjer for
nettoprovenyet. Liste over primærinnsidere som er omfattet av utøvelsen følger
vedlagt.
Samlet utstedte opsjoner for Orkla er etter disse transaksjonene 14Â 967 000
opsjoner.
Orkla har en sikring gjennom et finansielt, kontantavregnet derivat på 600 000
underliggende aksjer knyttet til opsjonsprogrammene.
Orkla eier 11Â 147 267 egne aksjer.
Orkla ASA,
Oslo, 16. desember 2009
Kontakt Orkla Investor Relations:
Siv Merethe S. Brekke, Tel: +47Â 930 56093
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
[HUG#1362220]
Primærinnsidere transaksjon 15 12 09 :
http://hugin.info/111/R/1362220/332557.pdf
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.